OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex biologics. Optimizing these processes involves modifying various parameters, including cell line development, media composition, and bioreactor conditions. A key goal is to maximize antibody yield while reducing production financi